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The inactivation of Cryptosporidium oocysts is a main driver in the selection of water treatment disinfection
strategies, and microbial risk analysis provides a sound basis for optimizing water treatment processes. U.S.
Environmental Protection Agency method 1622/23 provides an estimate of the total oocyst count; however, it
cannot be used directly for risk assessment, as it does not determine the fraction of infectious oocysts.
Improved assessment of the risk for designated sources or in treated water requires evaluation of the total
number of oocysts and an estimate of their infectivity. We developed a dual direct detection method using
differential immunofluorescent staining that allows detection of both oocysts and cell culture infection foci for
each sample. Using Cryptosporidium parvum oocysts, various pH levels, proteases, and gastroenteric com-
pounds and substrates were assessed to determine their abilities to enhance the number of infection foci. The
results showed that the key trigger for oocyst stimulation was acidification. Addition of a low concentration of
D-glucose (50 mM) to the infection media increased rates of infectivity, while a higher dose (300 mM) was
inhibitory. The total number of oocysts in each sample was determined by counting the oocysts remaining on
a cell monolayer and the oocysts recovered from cell monolayer washes during processing using a simple
filtration technique. With the dual direct detection on cell culture with immunofluorescence assay method, it
is now possible to determine the numbers of total and infectious oocysts for a given sample in a single analysis.
Direct percentages of infectivity are then calculated, which allows more accurate assessments of risk.
Over the past two decades, Cryptosporidium has been one of
the most frequently identified etiologic agents associated with
drinking water-borne illness outbreaks in the United States (8)
and England and Wales (41), and it has been associated with
23.7% of protozoan outbreaks worldwide (23). In response to
the emergence of this pathogen, increasingly stringent regula-
tions regarding the removal of Cryptosporidium oocysts have
been promulgated in the United States (44–46). The require-
ments for removal of Cryptosporidium during treatment are
based on estimates of the total number of oocysts in raw water,
and the average annualized incremental treatment costs asso-
ciated with these requirements have been estimated to range
from $92 million to $133 million (45). U.S. Environmental
Protection Agency (USEPA) method 1622/23 (46) for the de-
tection of Cryptosporidium in water provides a total oocyst
count, but it is not ideal for characterization of risk aimed at
optimizing water treatment from both the infrastructure in-
vestment and public health protection perspectives (45).
Method 1622/23 does not determine whether the oocysts de-
tected are capable of infecting humans or if they are infectious.
In the risk analysis conducted by the USEPA, the proportion
of the oocysts measured by the Information Collection Rule
Supplement Surveys (ICRSS) that were estimated to be infec-
tious was described by a triangular distribution (minimum, 30;
maximum, 50), a method which is considered to be a source of
uncertainty in evaluating risk. The USEPA estimate was based
on the physical structure of the oocysts observed using method
1622 and research data from cell culture oocyst infectivity
studies and represented the most likely proportion of environ-
mental oocysts that were infectious (45). When method
1622/23 data are used, the distribution has a mode of 40%,
which is supported by the infectious fraction (37%) deter-
mined by LeChevallier et al. (27) and the USEPA (45). How-
ever, the proportion of infectious environmental oocysts may
vary widely from site to site. Between 4 and 20% of surface
water samples tested positive for this pathogen (10, 27, 35),
while approximately 40% of wastewater samples tested posi-
tive (18). In a survey of filtered, finished drinking water using
a cell culture assay, 1.4% of samples tested positive for infec-
tious Cryptosporidium, and for 27% (22 of 82) of the treatment
plants surveyed there was at least one positive sample (1).
Cryptosporidium is an obligate parasite that travels from host
to host in the form of an oocyst. Once the organism is ingested
by a human via contaminated food or water or via direct
contact, the body temperature and stomach acidity (pH 1.5 to
3.5) trigger oocyst excystation (24). The oocysts are then car-
ried to the small intestine, where the chyme is alkalanized at
pH 8. Bile salts secreted at this point could also promote
excystation (24). Trypsin, the precursor of which is secreted by
the pancreas, then enters the small intestine. Trypsin in an
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acidified buffer is considered to be a suitable in vitro excysta-
tion treatment (20) and a stimulant of sporozoite motility (42).
In the small intestine, excysted sporozoites colonize entero-
cytes, forming parasitophorous vacuoles. Bile salts, especially
sodium taurocholate, appear to enhance invasion of sporozo-
ites by boosting their proteinic secretions and their gliding
motility (14).
The methods available to estimate oocyst infectivity vary
considerably in their oocyst stimulation and infection condi-
tions, as well as in their application (e.g., water, wastewater,
method development, biological study, disinfection assay, drug
assay, etc.) (Table 1). Ice-cold bleach and acidified Hanks’
balanced salts buffer (AHBSS) supplemented with trypsin at
body temperature are used as stimulation media. Bile or its
salts have also been used as the stimulating agent in one study,
and the results compared positively to the results obtained with
bleach treatment (19). Cell culture medium supplemented with
10% fetal bovine serum (FBS) is widely used. Other supple-
ments (vitamins, bile salts, sugars, and antibiotics) can also be
added. Another important variation in the methods is the
infection criteria, which are dependent on the objective of the
method. For example, if the objective is to quantify the impact
of stimulation and the infection medium conditions on the
motility or pattern of observable infection under simulated
conditions, then a method analyzing life stages or focus density
is used. In contrast, if the goal is to estimate the number of
infectious foci, then direct focus counting or the most-proba-
ble-number (MPN) method is more suitable. However, the use
of MPN with a low concentration of organisms, which is often
the case with Cryptosporidium oocysts in environmental sam-
ples, is limited (5).
Regulatory occurrence data sets collected using method
1622/23 for drinking water supplies report total oocyst counts
(43, 45, 46), but these total counts do not provide a basis on
which to estimate the proportion of infectious oocysts found in
the environment (10). Quantification of this fraction is needed
to reduce uncertainties and improve risk analysis (45). Current
analytical approaches have a substantial shortcoming as they
require a given sample to be divided for multiple analysis. For
example, a fraction of the sample is analyzed by an immuno-
fluorescence detection assay to determine the total number of
oocysts (e.g., method 1622/23), and a distinct fraction is ana-
lyzed by cell culture to determine infectivity (e.g., cell culture-
immunofluorescence assay [CC-IFA]). Consequently, the
physical division of samples results at best in indirect estima-
tion of the proportion of infectious oocysts. For example, in
one study examining surface water that used the split sample
approach, 593 samples were analyzed using method 1622/23
and 560 samples were analyzed using a cell culture infectivity
assay (some split samples were lost, resulting in the different
numbers of samples assayed) (27). The authors reported that
60 of the method 1622/23 samples and 22 of the cell culture
infectivity assay samples tested positive, resulting in an esti-
mate that 37% of the oocysts detected were infectious. How-
ever, a Monte Carlo simulation of oocyst distribution and pos-
itive result probabilities was needed to support this estimate,
since only one set of split samples tested positive by both
assays.
The general objective of this study was to develop and op-
timize a method for combined detection of total and infectious
oocysts that could be used to improve assessment of Crypto-
sporidium risk. Several different oocyst stimulation treatments
and cell culture medium supplements were evaluated to opti-
mize the Cryptosporidium cell culture infectivity assay. Several
different commercial antibodies with different fluorochromes
were evaluated individually and in combination for immuno-
fluorescent detection of oocysts and cell culture infection foci.
MATERIALS AND METHODS
Source of Cryptosporidium oocysts. Viable Cryptosporidium parvum isolate
Iowa (Harley Moon) oocysts passaged through mice were purchased from
Waterborne Inc. (New Orleans, LA). All lots were used within 2 months post-
shedding and were stored at 4°C.
Cell culture. Human ileocecal adenocarcinoma HCT-8 cells (ATCC CCL-244)
were cultivated in RPMI 1640 medium containing GlutaMAX and 25 mM
HEPES buffer (Invitrogen Canada Inc., Burlington, Ontario, Canada) supple-
mented with 5% heat-inactivated fetal bovine serum (FBS) (Invitrogen Canada
Inc., Burlington, Ontario, Canada), 0.1 g kanamycin liter1, 100,000 U penicillin
G liter1, 100 mg streptomycin liter1, and 250 g amphotericin B liter1
(Calbiochem, San Diego, CA). Cells were grown in 75-cm2 culture flasks (BD
Falcon, VWR Canada) in a 5% CO2 atmosphere at 37°C. The cells were pas-
saged every 3 to 4 days. For infectivity studies, cells were seeded on Lab Tek II
multichamber slides (catalog no. 154534; Nalge Nunc, Naperville, IL) at a target
density of 2.2  104 cells per chamber in 500 l cell culture medium and
incubated in a 5% CO2 atmosphere at 37°C. Within 48 h, monolayers were
confluent. No cells that were passaged more than 25 times were used.
Oocyst stimulation pretreatment. Oocysts were pretreated by incubation in
acidified Hanks’ balanced salt solution (catalog no. H9269; Sigma-Aldrich, St.
Louis, MO) at pH 2 for 1 h at 37°C with vigorous vortex mixing for 10 s every 15
min (11). In the optimization experiments, various supplements were freshly
added, as follows: to the AHBSS, trypsin type II-S from porcine pancreas (cat-
alog no. T7409; Sigma-Aldrich, St. Louis, MO) and pepsin from porcine stomach
mucosa (catalog no. P7012; Sigma-Aldrich, St. Louis, MO); and to nonacidified
Hanks’ balanced salt solution (HBSS), bovine bile (catalog no. B3883; Sigma-
Aldrich, St. Louis, MO). These supplements were selected based on the results
of the studies shown in Table 1.
Infection of cell monolayers. Stimulated oocysts were washed twice using
prewarmed infection medium and microcentrifugation (17,000  g at room
temperature for 2 min without braking). The final volumes of inocula were
adjusted to 500 l. Inoculated cell monolayers were incubated for 72 h in a 5%
CO2 atmosphere at 37°C. For the control infection, cell culture infection medium
containing 10% FBS was used. To evaluate the effects on infectivity, the follow-
ing supplements were added to the infection medium: D-()-glucose (catalog no.
G8270; Sigma-Aldrich) and bovine bile (catalog no. B3883; Sigma-Aldrich).
These additions were selected based on the results of the studies shown in Table 1.
Detection of infection. Infection medium was removed from each slide cham-
ber, and monolayers were fixed with 500 l absolute methanol (catalog no.
65542; Sigma-Aldrich, Germany) for 10 min. The methanol was removed, and
the monolayers were air dried. Monolayers were then blocked for a minimum of
30 min on a rocking platform at room temperature using 500 l phosphate-
buffered saline (PBS) containing 0.002% Tween 20 (catalog no. BP337-100;
Fisher Scientific, Fair Lawn, NJ) and 2% goat serum (catalog no. G9023; Sigma-
Aldrich). The slides were subsequently washed with PBS twice and stained using
various antibodies. The antibodies tested were Cy3-labeled Crypt-a-Glo (catalog
no. A400CY3R-1X; Waterborne Inc., New Orleans, LA), Cy3-labeled Sporo-Glo
(catalog no. A600CY3R-1X; Waterborne Inc., New Orleans, LA), and fluores-
cein isothiocyanate (FITC)-labeled EasyStain GC Combo (catalog no. EST
CG80; BTF, Sydney, Australia) in 150 l. The antibody mixture dilutions (1/10,
1/50, 1/100) and wash buffers evaluated included PBS and BTF fixing buffer from
a BTF EasyStain kit. Slide chambers were removed, 2 drops of CitiFluor glyc-
erol-PBS AF1 (catalog no. CM 512-1; Canemca Marivac, Quebec, Canada)
mounting medium was added, coverslips were added, and the slides were sealed
with nail polish. Monolayers were observed to determine the presence of infec-
tion foci and oocysts at a magnification of 200 (600 for environmental sam-
ples) using an epifluorescence microscope (BX51; Olympus, Tokyo, Japan) with
FITC (U-N51006; Olympus, Tokyo, Japan) and Cy3 (U-N4107A; Olympus,
Tokyo, Japan) filters.
Filtration counting of oocysts. To count oocysts in solutions or to estimate
oocyst losses at various steps in the protocol, spent wash solutions were pro-
cessed using the following protocol. First, spent wash solutions were microcen-
VOL. 76, 2010 DETECTION OF CRYPTOSPORIDIUM BY 3D-CC-IFA 567
 o
n
 Septem
ber 11, 2018 by guest
http://aem
.asm
.org/
D
ow
nloaded from
 
T
A
B
L
E
1.
St
im
ul
at
io
n
co
nd
iti
on
s,
in
fe
ct
io
n
m
ed
ia
,a
nd
in
fe
ct
io
n
cr
ite
ri
a
us
ed
in
va
ri
ou
s
C
ry
pt
os
po
rid
iu
m
vi
ab
ili
ty
an
d
in
fe
ct
iv
ity
st
ud
ie
s
R
ef
er
en
ce
c
O
bj
ec
tiv
e
Si
m
ul
at
ed
m
ed
ia
a
In
fe
ct
io
n
cr
ite
ri
a
C
om
m
en
ts
St
im
ul
at
io
n
In
fe
ct
io
n
4
M
et
ho
d
de
ve
lo
pm
en
t
A
H
B
SS
(p
H
2.
75
),
1
h
at
37
°C
4
h
at
37
°C
in
ei
th
er
H
an
ks
’M
E
M
w
ith
0.
57
%
bo
vi
ne
bi
le
an
d
0.
06
%
N
aH
C
O
3
or
H
B
SS
w
ith
0.
08
%
so
di
um
de
ox
yc
ho
la
te
an
d
0.
18
%
N
aH
C
O
3
E
xc
ys
ta
tio
n,
D
A
PI
po
si
tiv
e
D
ilu
te
d
ac
id
m
im
ic
s
in
vi
vo
m
or
e,
w
ith
no
si
gn
ifi
ca
nt
oo
cy
st
de
at
h;
0.
1
M
N
aO
H
-0
.1
M
H
C
li
nc
re
as
ed
oo
cy
st
de
at
h;
at
te
m
pe
ra
tu
re
s
ab
ov
e
37
°C
,
sp
or
oz
oi
te
s
do
no
t
su
rv
iv
e;
at
te
m
pe
ra
tu
re
s
be
lo
w
37
°C
,l
itt
le
ef
fe
ct
on
ex
cy
st
at
io
n
47
M
et
ho
d
de
ve
lo
pm
en
t
10
%
bl
ea
ch
,1
0
m
in
at
4°
C
R
PM
I
16
40
w
ith
10
%
F
B
S,
15
m
M
H
E
PE
S,
50
m
M
gl
uc
os
e,
3.
5%
as
co
rb
ic
ac
id
,0
.1
%
fo
lic
ac
id
,0
.4
%
4-
am
in
ob
en
zo
ic
ac
id
,0
.2
%
ca
lc
iu
m
pa
nt
ot
he
na
te
,0
.1
U
/m
li
ns
ul
in
,1
00
U
/m
lp
en
ic
ill
in
G
,1
0%
st
re
pt
om
yc
in
,
an
d
0.
02
5%
am
ph
ot
er
ic
in
B
(p
H
7.
4)
L
ife
st
ag
e
co
un
t
T
w
en
ty
-fi
ve
m
ed
iu
m
su
pp
le
m
en
ts
ex
am
in
ed
;i
nf
ec
tiv
ity
en
ha
nc
er
s
in
cl
ud
ed
10
%
F
B
S,
su
ga
rs
(g
lu
co
se
,
ga
la
ct
os
e,
m
al
to
se
,m
an
no
se
),
in
su
lin
,a
nd
vi
ta
m
in
s
(a
sc
or
bi
c
ac
id
,
ca
lc
iu
m
pa
nt
ot
he
na
te
,f
ol
ic
ac
id
,
pa
ra
-a
m
in
ob
en
zo
ic
ac
id
)
38
M
et
ho
d
de
ve
lo
pm
en
t
10
.5
%
bl
ea
ch
,1
0
m
in
at
4°
C
R
PM
I
16
40
w
ith
10
%
F
B
S,
2
m
M
L
-g
lu
ta
m
in
e,
an
d
20
m
M
H
E
PE
S
F
oc
us
de
te
ct
io
n
m
et
ho
d
D
et
ec
ts
m
or
e
fo
ci
th
an
se
ed
ed
oo
cy
st
s
9
O
cc
ur
re
nc
e
in
na
tu
ra
lw
at
er
an
d
fil
te
r
ba
ck
w
as
h
A
H
B
SS
-1
%
tr
yp
si
n,
1
h
at
37
°C
R
PM
I
16
40
w
ith
L
-g
lu
ta
m
in
e,
10
%
F
B
S,
15
m
M
H
E
PE
S,
50
m
M
gl
uc
os
e,
35
m
g/
lit
er
as
co
rb
ic
ac
id
,1
.0
m
g/
lit
er
fo
lic
ac
id
,4
.0
m
g/
lit
er
4-
am
in
ob
en
zo
ic
ac
id
,2
.0
m
g/
lit
er
ca
lc
iu
m
pa
nt
ot
he
na
te
,1
00
,0
00
U
/li
te
r
pe
ni
ci
lli
n
G
,1
00
m
g/
lit
er
st
re
pt
om
yc
in
,7
00
m
g/
lit
er
am
ph
ot
er
ic
in
B
,a
nd
12
.5
m
g/
lit
er
te
tr
ac
yc
lin
e
PC
R
po
si
tiv
e
N
ot
qu
an
tit
at
iv
e
32
IM
S
co
m
pa
ri
so
n
H
B
SS
w
ith
0.
7%
bi
le
an
d
5
m
M
N
aH
C
O
3
,3
h
at
37
°C
E
ag
le
M
E
M
or
R
PM
I
16
40
w
ith
0.
1%
bo
vi
ne
se
ru
m
al
bu
m
in
Sp
or
oz
oi
te
in
fe
ct
io
n
de
te
rm
in
ed
by
PC
R
de
te
ct
io
n
O
oc
ys
ts
ex
cy
st
ed
w
hi
le
in
co
m
pl
ex
;
sp
or
oz
oi
te
pu
ri
fic
at
io
n
pr
io
r
to
in
fe
ct
io
n
40
M
et
ho
d
de
ve
lo
pm
en
t,
di
si
nf
ec
tio
n
st
ud
y
10
.5
%
bl
ea
ch
,5
to
8
m
in
at
4°
C
R
PM
I
16
40
w
ith
10
%
F
B
S,
2
m
M
L
-g
lu
ta
m
in
e,
an
d
20
m
M
H
E
PE
S
M
PN
C
om
pa
ra
bl
e
w
ith
an
im
al
in
fe
ct
iv
ity
17
Su
rv
iv
al
as
sa
y
0.
5%
pe
ps
in
-0
.7
%
H
C
l-0
.9
%
N
aC
lf
or
30
m
in
at
37
°C
;2
.2
%
N
aH
C
O
3
-
0.
22
%
so
di
um
ta
ur
oc
ho
la
te
-0
.0
4%
bo
vi
ne
tr
yp
si
n
fo
r
12
0
m
in
at
37
°C
N
ot
ap
pl
ic
ab
le
E
m
pt
y
oo
cy
st
s
E
xc
ys
ta
tio
n
pr
ot
oc
ol
;9
5%
ex
cy
st
at
io
n
ob
ta
in
ed
28
D
ru
g
as
sa
y
B
le
ac
h
N
ot
de
sc
ri
be
d
F
lu
or
es
ce
nc
e
in
te
ns
ity
re
ad
by
en
zy
m
e-
lin
ke
d
im
m
un
os
or
be
nt
as
sa
y
pl
at
e
co
un
te
r
R
es
ul
ts
co
m
pa
ra
bl
e
to
an
im
al
as
sa
y
re
su
lts
19
M
et
ho
d
de
ve
lo
pm
en
t
N
on
e
R
PM
I
16
40
w
ith
10
%
F
B
S,
15
m
M
H
E
PE
S,
50
m
M
gl
uc
os
e,
3.
5%
as
co
rb
ic
ac
id
,0
.1
%
fo
lic
ac
id
,0
.4
%
4-
am
in
ob
en
zo
ic
ac
id
,0
.2
%
ca
lc
iu
m
pa
nt
ot
he
na
te
,0
.1
U
/m
li
ns
ul
in
,1
00
U
/m
lp
en
ic
ill
in
G
,1
0%
st
re
pt
om
yc
in
,
0.
02
5%
am
ph
ot
er
ic
in
B
(p
H
7.
4)
,a
nd
0.
37
5%
so
di
um
ta
ur
oc
ho
la
te
Pa
ra
si
te
co
un
t
at

1,
00
0
m
ag
ni
fic
at
io
n
So
di
um
ta
ur
oc
ho
la
te
be
tt
er
th
an
bl
ea
ch
;n
o
st
im
ul
at
io
n
re
qu
ir
ed
w
ith
so
di
um
ta
ur
oc
ho
la
te
48
M
et
ho
d
de
ve
lo
pm
en
t
10
%
bl
ea
ch
,8
m
in
at
4°
C
R
PM
I
16
40
w
ith
10
%
F
B
S,
O
pt
i-M
E
M
,
an
d
Pe
n-
St
ep
t-
A
m
ph
M
PN
an
d
fo
cu
s
co
un
t
C
en
tr
ifu
ge
-s
tim
ul
at
ed
oo
cy
st
s
on
ce
ll
m
on
ol
ay
er
s
sh
or
te
n
in
fe
ct
io
n
tim
e
33
D
is
in
fe
ct
io
n
as
sa
y,
co
m
pa
ra
tiv
e
st
ud
y
R
PM
I
w
ith
0.
75
%
so
di
um
ta
ur
oc
ho
la
te
,1
0
m
in
at
37
°C
R
PM
I
16
40
w
ith
4
m
M
L
-g
lu
ta
m
in
e,
2%
F
B
S,
30
m
M
H
E
PE
S,
10
0
U
/m
l
pe
ni
ci
lli
n,
10
0
g/
m
ls
tr
ep
to
m
yc
in
,1
00
g/
m
lk
an
am
yc
in
,a
nd
0.
25
g/
m
l
am
ph
ot
er
ic
in
B
M
PN
an
d
fo
cu
s
co
un
t
In
cu
ba
tio
n
w
ith
so
di
um
ta
ur
oc
ho
la
te
in
cr
ea
se
s
oo
cy
st
in
fe
ct
iv
ity
;
in
fe
ct
iv
ity
co
m
pa
ra
bl
e
to
an
im
al
in
fe
ct
iv
ity
568 LALANCETTE ET AL. APPL. ENVIRON. MICROBIOL.
 o
n
 Septem
ber 11, 2018 by guest
http://aem
.asm
.org/
D
ow
nloaded from
 
18
O
cc
ur
re
nc
e
in
a
w
as
te
w
at
er
tr
ea
tm
en
t
pl
an
t
10
%
bl
ea
ch
,8
m
in
at
ro
om
te
m
pe
ra
tu
re
G
ro
w
th
m
ed
iu
m
M
PN
27
O
cc
ur
re
nc
e
in
ri
ve
r
w
at
er
A
H
B
SS
-1
%
tr
yp
si
n,
1
h
at
37
°C
R
PM
I
16
40
w
ith
L
-g
lu
ta
m
in
e,
10
%
F
B
S,
15
m
M
H
E
PE
S,
50
m
M
gl
uc
os
e,
35
m
g/
lit
er
as
co
rb
ic
ac
id
,1
.0
m
g/
lit
er
fo
lic
ac
id
,4
.0
m
g/
lit
er
4-
am
in
ob
en
zo
ic
ac
id
,2
.0
m
g/
lit
er
ca
lc
iu
m
pa
nt
ot
he
na
te
,1
00
,0
00
U
/li
te
r
pe
ni
ci
lli
n
G
,1
00
m
g/
lit
er
st
re
pt
om
yc
in
,7
00
m
g/
lit
er
am
ph
ot
er
ic
in
B
,a
nd
12
.5
m
g/
lit
er
te
tr
ac
yc
lin
e
PC
R
po
si
tiv
e
R
ep
or
te
d
C
C
-P
C
R
in
fe
ct
iv
ity
-p
os
iti
ve
sa
m
pl
es
co
m
pa
re
d
to
pa
ir
ed
sa
m
pl
es
an
d
m
et
ho
d
16
23
po
si
tiv
e
w
ith
pa
ir
ed
sa
m
pl
es
30
M
et
ho
d
de
ve
lo
pm
en
t
2
m
M
so
di
um
ta
ur
oc
ho
la
te
,1
0
m
in
at
15
°C
,5
to
8
m
in
at
37
°C
N
ot
sp
ec
ifi
ed
D
et
ec
tio
n
of
in
fe
ct
ed
ce
lls
by
flo
w
cy
to
m
et
ry
C
or
re
la
te
d
w
ith
IF
A
vi
su
al
co
un
t;
le
ss
op
er
at
or
bi
as
;f
as
te
r
31
O
cc
ur
re
nc
e
in
re
cl
ai
m
ed
w
at
er
,c
om
pa
ri
so
n
of
m
et
ho
d
10
%
bl
ea
ch
,8
m
in
at
ro
om
te
m
pe
ra
tu
re
R
PM
I
16
40
w
ith
10
%
F
B
S,
20
m
M
H
E
PE
S,
2
m
M
L
-g
lu
ta
m
in
e,
an
d
10
%
O
pt
i-M
E
M
F
D
M
-M
PN
R
ep
ro
du
ci
bl
e
an
d
se
ns
iti
ve
1
O
cc
ur
re
nc
e
in
fil
te
re
d
dr
in
ki
ng
w
at
er
A
H
B
SS
-1
%
tr
yp
si
n,
1
h
at
37
°C
R
PM
I
16
40
w
ith
L
-g
lu
ta
m
in
e,
10
%
F
B
S,
15
m
M
H
E
PE
S,
50
m
M
gl
uc
os
e,
35
m
g/
lit
er
as
co
rb
ic
ac
id
,1
.0
m
g/
lit
er
fo
lic
ac
id
,4
.0
m
g/
lit
er
4-
am
in
ob
en
zo
ic
ac
id
,2
.0
m
g/
lit
er
ca
lc
iu
m
pa
nt
ot
he
na
te
,1
00
,0
00
U
/li
te
r
pe
ni
ci
lli
n
G
,1
00
m
g/
lit
er
st
re
pt
om
yc
in
,7
00
m
g/
lit
er
am
ph
ot
er
ic
in
B
,a
nd
12
.5
m
g/
lit
er
te
tr
ac
yc
lin
e
PC
R
po
si
tiv
e
U
se
d
gp
60
re
gi
on
to
di
ffe
re
nt
ia
te
en
vi
ro
nm
en
ta
li
so
la
te
s
fr
om
la
b
co
nt
ro
ls
20
B
io
lo
gi
ca
ls
tu
dy
0.
5%
tr
yp
si
n
at
pH
2.
5
to
3
fo
r
20
m
in
at
37
°C
;R
PM
I
16
40
w
ith
0.
03
%
L
-g
lu
ta
m
in
e,
0.
3%
N
a 2
C
O
3
,0
.0
2%
bo
vi
ne
bi
le
,0
.1
%
gl
uc
os
e,
0.
02
5%
fo
lic
ac
id
,0
.1
%
4-
am
in
ob
en
zo
ic
ac
id
,0
.0
50
%
ca
lc
iu
m
pa
nt
ot
he
na
te
,
0.
87
5%
as
co
rb
ic
ac
id
,1
%
fe
ta
lc
al
f
se
ru
m
,0
.3
6%
H
E
PE
S
bu
ffe
r,
1,
00
0
U
/li
te
r
pe
ni
ci
lli
n
G
,a
nd
0.
01
%
st
re
pt
om
yc
in
at
pH
7.
4
N
ot
ap
pl
ic
ab
le
C
om
pl
et
e
lif
e
cy
cl
e
C
el
l-f
re
e
cu
ltu
re
10
M
et
ho
d
de
ve
lo
pm
en
t
A
H
B
SS
-1
%
tr
yp
si
n,
1
h
at
37
°C
R
PM
I
16
40
w
ith
L
-g
lu
ta
m
in
e,
10
%
F
B
S,
15
m
M
H
E
PE
S,
50
m
M
gl
uc
os
e,
35
m
g/
lit
er
as
co
rb
ic
ac
id
,1
.0
m
g/
lit
er
fo
lic
ac
id
,4
.0
m
g/
lit
er
4-
am
in
ob
en
zo
ic
ac
id
,2
.0
m
g/
lit
er
ca
lc
iu
m
pa
nt
ot
he
na
te
,1
00
,0
00
U
/li
te
r
pe
ni
ci
lli
n
G
,1
00
m
g/
lit
er
st
re
pt
om
yc
in
,7
00
m
g/
lit
er
am
ph
ot
er
ic
in
B
,a
nd
12
.5
m
g/
lit
er
te
tr
ac
yc
lin
e
PC
R
po
si
tiv
e
F
as
te
r
de
te
ct
io
n;
qu
an
tit
at
iv
e
PC
R
de
te
ct
io
n;
no
t
fo
r
di
si
nf
ec
tio
n
as
sa
y
(b
ac
kg
ro
un
d
si
gn
al
at
hi
gh
le
ve
ls
of
oo
cy
st
in
oc
ul
a)
;s
ta
nd
ar
d
cu
rv
e
no
t
un
iv
er
sa
l
35
O
cc
ur
re
nc
e
in
su
rf
ac
e
w
at
er
A
H
B
SS
(p
H
2.
7)
fo
r
1
h
at
37
°C
;1
%
bo
vi
ne
bi
le
-0
.4
4%
N
aH
C
O
3
fo
r
30
m
in
at
37
°C
D
ul
be
cc
o
m
od
ifi
ed
E
ag
le
m
ed
iu
m
w
ith
25
m
M
H
E
PE
S,
45
%
gl
uc
os
e,
10
%
F
B
S,
0.
1%
M
E
M
-N
E
A
A
,0
.1
%
L
-g
lu
ta
m
in
e,
an
d
0.
00
5%
ge
nt
am
ic
in
F
oc
ia
nd
50
%
in
fe
ct
io
us
do
se
A
ss
ay
no
t
se
ns
iti
ve
en
ou
gh
fo
r
lo
w
en
vi
ro
nm
en
ta
lc
ou
nt
s
3
M
et
ho
d
de
ve
lo
pm
en
t
A
H
B
SS
R
PM
I
w
ith
0.
05
%
bi
le
F
oc
us
co
un
t
B
lin
d
tr
ia
ld
em
on
st
ra
te
s
th
at
C
C
-I
F
A
is
a
go
od
su
rr
og
at
e
fo
r
an
im
al
in
fe
ct
iv
ity
21
b
M
et
ho
d
de
ve
lo
pm
en
t
A
H
B
SS
(p
H
2)
-1
%
tr
yp
si
n,
1
h
at
37
°C
R
PM
I
16
40
w
ith
L
-g
lu
ta
m
in
e,
10
%
F
B
S,
10
0,
00
0
U
/li
te
r
pe
ni
ci
lli
n
G
,1
00
m
g/
lit
er
st
re
pt
om
yc
in
,a
nd
70
0
m
g/
lit
er
am
ph
ot
er
ic
in
B
F
oc
us
co
un
t
R
ef
er
en
ce
C
C
-I
F
A
pr
ot
oc
ol
a
A
bb
re
vi
at
io
ns
:M
E
M
,m
in
im
al
es
se
nt
ia
lm
ed
iu
m
;D
A
PI
,4
,6
-
di
am
id
in
o-
2-
ph
en
yl
in
do
le
;P
en
-S
te
pt
-A
m
ph
,p
en
ic
ill
in
-s
tr
ep
to
m
yc
in
-a
m
ph
ot
er
ic
in
B
;F
D
M
,f
oc
us
de
te
ct
io
n
m
et
ho
d;
N
E
A
A
,n
on
es
se
nt
ia
la
m
in
o
ac
id
.
b
R
ef
er
en
ce
m
et
ho
d.
c
R
ef
er
en
ce
s
ar
e
lis
te
d
fr
om
th
e
ol
de
st
to
th
e
m
os
t
re
ce
nt
st
ud
ie
s.
VOL. 76, 2010 DETECTION OF CRYPTOSPORIDIUM BY 3D-CC-IFA 569
 o
n
 Septem
ber 11, 2018 by guest
http://aem
.asm
.org/
D
ow
nloaded from
 
trifuged at 17,000  g for 2 min. The pellets were suspended in 100 l of a 1/50
dilution of BTF GC Combo antibodies in BTF fixing buffer for 2 h at room
temperature on a rocking platform at low speed. Stained oocysts were washed
once with 500 l BTF fixing buffer and centrifuged again. The pellets were
suspended in 500 l BTF fixing buffer and vacuum filtered through a 0.45-m
polycarbonate filter (catalog no. HAWGO4756; Millipore, Billerica, MA). The
tip and tube used were rinsed with 200 l of BTF fixing buffer, and the rinse
solution was passed through the filter to maximize oocyst recovery. The unused
edges of the filter were removed using flame-sterilized scissors, and the filter was
placed on a microscopic slide. CitiFluor glycerol-PBS AF1 (catalog no. CM
512-1; Canemca Marivac, Quebec, Canada) was used as a mounting medium.
The reproducibility of staining characteristics for a 1/10 dilution of Crypt-a-Glo
in PBS and a 1/50 dilution of GC Combo in BTF fixing buffer was evaluated using
three replicates of the same oocyst stock suspension.
Rate of excystation of stimulated oocysts. Oocyst suspensions were subjected
to a stimulation pretreatment and then were examined to determine rates of
excystation. Oocysts were observed by differential interference contrast micros-
copy at a magnification of 1,000. The first 75 randomly encountered oocysts
were determined to be intact or excysted.
Effect of the proportion of UV-killed oocysts on cell culture infectivity and
oocyst retention on monolayers. Untreated and UV-inactivated (100 mJ/cm2;
253.7 nm; collimated beam) oocyst suspensions containing approximately 500
oocysts were mixed using different proportions (0:1, 1:4, 1:2, 3:4, 1:0). Foci and
oocysts on the cell monolayers were enumerated.
Recovery with the dual direct detection (3D)-CC-IFA method. For method
recovery trials and seeded environmental matrices, oocyst inocula (500 oocysts)
were prepared using flow cytometry by the Wisconsin State Laboratory of Hy-
giene. Oocysts were added to the optimized pretreatment stimulation medium
(AHBSS without trypsin). Once stimulated, the oocysts were infected in the
optimized infection medium (with 50 mM glucose). Detection was performed
using the Sporo-Glo stain for infection foci and BTF GC Combo for oocyst
detection on cell monolayers and in spent monolayer wash solutions.
Spiked environmental assay for study of recovery from IMS purification. Grab
samples of water from the Yamaska River and Mille-Iles River (Quebec, Can-
ada) were repeatedly centrifuged at 1,500  g for 15 min until one 0.5-ml pellet
per immunomagnetic separation (IMS) reaction was formed. Five milliliters of
supernatant was kept above the 0.5-ml pellet, and vigorous vortexing was used to
homogenize the pellet. This concentrate and oocysts were added to the IMS
protocol Leighton tube, and the preparation was vortex mixed vigorously. IMS
capture was performed twice according to the Dynabeads anti-Cryptosporidium
kit (catalog no. 730-01; Invitrogen Canada, Burlington, Ontario, Canada) and
USEPA method 1622 protocol instructions (46). The complexes were then dis-
sociated during the pretreatment stimulation step of the 3D-CC-IFA method,
and beads were removed after 1 h of incubation at 37°C. To avoid fungal
contamination, 240,000 U nystatin liter1 (catalog no. N1638; Sigma-Aldrich, St.
Louis, MO) was added to the infection medium.
Direct and indirect calculations of the percentage of infectious oocysts from
the CC-IFA data. Data for infectious foci from either environmental samples or
spiked oocysts are reported based on the corresponding total oocyst counts. The
ratios could be obtained either indirectly or directly. The indirect enumeration
method required a split sample (e.g., number of IMS-purified oocysts divided
into the total number and the number determined by the infectious methods),
and each subsample provided either a count of infectious oocysts (i.e., infectious
foci) in a cell culture assay or total oocyst counts determined by USEPA method
1623. In the direct (3D-CC-IFA) enumeration method, the numbers of total and
infectious oocysts were determined for a single sample in a single analysis.
RESULTS
Reference counts. Results obtained with various medium
formulations were compared to results obtained with the ref-
erence method described by Johnson et al. (21) (Table 1). The
reference method uses AHBSS-1% trypsin as the stimulation
pretreatment and RPMI medium with 10% FBS plus antibi-
otics as the infection medium. When all results were compared
to the results obtained with the reference method, the mean
percentages of oocyst infectivity (number of foci reported for
the number of oocysts inoculated) were 7.4% 4.0% (n 25).
All results were then expressed as a ratio of the number of foci
to the number of foci obtained with the AHBSS-1% trypsin
reference method. Also, Fig. 1 shows an overview of the whole
3D-CC-IFA method.
Stimulation pretreatment. Figure 2 shows that treatment of
oocysts with trypsin at concentrations equal to or less than 1%
can slightly increase the number of cell culture infection foci.
At higher concentrations, a significant decrease (for 0.25 to 1%
trypsin compared with 2% trypsin, P  0.05) in the number of
infection foci was observed. Addition of pepsin did not in-
crease the level of infection (for 1% pepsin compared with
0.25% pepsin, P 	 0.1), and at higher concentrations (	0.5%)
the number of foci detected was significantly decreased (for
0.06 to 0.5% pepsin compared with 1 to 2% pepsin, P  0.01).
Based on these results, AHBSS was selected as the stimulation
pretreatment. Levels of oocyst excystation (which is undesir-
able) during the 1-h stimulation treatment were determined
and were found to be only 1.3% for AHBSS containing 1%
trypsin and less than 1.3% for AHBSS alone.
Addition of bile to stimulation and infection media. Figure
3 shows the impact of adding bile to stimulation and infection
media at neutral pH in order to mimic pH conditions found in
the duodenum. Bile clearly inhibits focus development when it
is added at either step.
Optimization of infection media. Figure 4 shows that addi-
tion of glucose to the infection media at concentrations greater
than the reference concentration (10 mM) influenced the num-
ber of infectious foci. At a concentration of 50 mM, a signifi-
cant increase (for AHBSS pretreatment with 10 mM glucose
compared with AHBSS pretreatment with 50 mM glucose in
infection media, P  0.1) in the number of foci was noted, but
at a higher concentration (300 mM), glucose inhibited infectivity.
Other concentrations did not result in significant changes.
Dual detection: sources of oocyst loss during sample pro-
cessing. To estimate oocyst losses at various steps of the CC-
IFA procedure, spent wash solutions were processed using
membrane filtration to recover any oocysts present. Figure 5
shows the levels of oocysts recovered from spent wash solu-
tions at different steps during sample processing. As antici-
pated, the stimulation step wash solutions accounted for only a
small portion (3.7%  2.4%) of the total oocyst loss compared
to the postinfection steps (28.0%  4.7%) and the loss on the
cell monolayer (39.6%  7.0%); 32.5%  10% of the oocysts
FIG. 1. Summary of the steps of the final 3D-CC-IFA method.
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were not accounted for. The sources of the losses are not clear,
but the losses may well have been the result of the manipula-
tions. Importantly, the variations in these results is low, and
therefore the results can be reproduced.
Dual detection: what could influence oocyst adhesion to the cell
monolayer? To assess the impact of viability on adherence, CC-
IFA was performed with mixtures containing increasing propor-
tions of UV-inactivated oocysts. Figure 6 shows that inactivated
oocysts were retained on the cell monolayer to the same extent as
untreated oocysts. The decrease in the percentage of infectious
foci ranged from approximately 0 to 100% and was proportional
to the increasing fraction of UV-inactivated oocysts.
The impact of using low-volume inocula to promote contact
of oocysts with cell monolayers was assessed. The use of up to
7 h of incubation with a low inoculum volume (100 l) before
the remaining infection medium (total volume, 500 l) was
FIG. 2. Impact of addition of trypsin and pepsin in the stimulation pretreatment (AHBSS for 1 h at 37°C) on the number of C. parvum cell
culture infection foci (combined data from one to five experiments; n  3 to 15). N, number.
FIG. 3. Impact of addition of bile to the stimulation medium (pH 7.4) and infection medium (IM) on the number of C. parvum cell culture
infection foci and calculation of the percentages of infectious oocysts in the inocula (n  2). The bars indicate the ranges. N, number.
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added did not significantly influence (P 		 0.1) oocyst reten-
tion (data not shown) or the development of foci. The impact
of the incubation time (i.e., 72, 96, and 120 h) on the retention
of oocysts on cell monolayers was also investigated, and incu-
bation time was found to not affect oocyst retention on mono-
layers greatly (data not shown). On the basis of these results,
we elected to incorporate estimation of the number of oocysts
in postinfection waste streams in the method instead of con-
tinuing to attempt to optimize oocyst retention. General mi-
croscopic observations of the infected cell monolayers and
waste solutions did not reveal any trends in the preferential
retention of full or open oocysts or in the simultaneous pres-
ence of foci and open or intact oocysts.
Selection of antibodies. For the filtration counting, Crypt-a-
Glo (Waterborne Inc.) and GC Combo (BTF) were compared
using a reference oocyst suspension that was counted in trip-
licate. The results showed that there was no significant differ-
ence between Crypt-a-Glo (Waterborne Inc.) (437  68 oo-
FIG. 4. Effect of glucose concentration on the development of infection foci (combined data from one to five experiments; n  3 to 11). Pep,
pepsin; Tryp, trypsin; N, number.
FIG. 5. Recovery of oocysts during processing steps of the CC-IFA method (n  15). For the stimulation and postinfection processing steps
oocysts were recovered from spent sample wash solutions by filtration.
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cysts) and GC Combo (BTF) diluted 1/100 (458  35 oocysts)
(P 		 0.1). For detection of oocysts and infection foci on cell
monolayers, various antibodies were investigated either alone
or in combination. The results demonstrated that Crypt-a-Glo
detected both foci and oocysts, while Sporo-Glo and GC
Combo detected foci and oocysts, respectively. The lowest
level of background staining was observed with the following
conditions: 1/10 dilution of Crypt-a-Glo in PBS for 1 h at room
temperature; 1/10 dilution of Sporo-Glo in PBS for 1 h at room
temperature; and 1/10 dilution of GC Combo in BTF fixing
buffer for 1 h at room temperature. Although there was no
significant difference in the counts (data not shown), combin-
ing Cy3-labeled Sporo-Glo with FITC-labeled GC Combo in
BTF fixing buffer facilitated and clarified observation of both
oocysts and infection foci (Fig. 7).
3D-CC-IFA recovery studies. Using flow cytometry-sorted oo-
cyst samples, the levels of recovery for 3D-CC-IFA alone were
68%  11% (n  10). The calculated percentage of infectious
oocysts in the inocula varied depending on the reference count
used, as follows: 12%  1% using indirect counts (number of
foci/number of inoculated oocysts) and 19%  4% based on
direct counts of recovered oocysts (number of foci/number of
3D-CC-IFA-counted oocysts) (Fig. 8 and Table 2). For recovery
by the 3D-CC-IFA method including upstream IMS, flow-sorted
oocysts were spiked into MilliQ water at the IMS step, resulting in
levels of recovery of 64%  9% (n  3). For these samples, the
percentages of infectivity for indirect calculation were 9%  0%,
and for direct calculation the percentages of infectivity were
14%  2%. For Yamaska River water, levels of IMS and 3D-
CC-IFA recovery of 25%  19% (n 3) were observed, and the
levels of infectivity varied from 4%  3% for the indirect calcu-
lation to 19%  15% for the direct calculation. For Mille Iles
River water, levels of IMS and 3D-CC-IFA recovery of 41% 
14% (n  2) were obtained, and the levels of infectivity varied
from 5%  1% for the indirect calculation to 13%  3% for the
direct calculation (Fig. 8 and Table 2).
DISCUSSION
Impact of the medium selected on pretreatment. Most work-
ers have obtained stimulation using an acidified buffer
amended with 1% trypsin and have indicated that trypsin acts
FIG. 6. Adherence of UV-inactivated oocysts (100 mJ/cm2 with
collimated beam) to cell monolayers (n  3). The errors bars indicate
standard deviations.
FIG. 7. Superimposed 3D-CC-IFA images (magnification, 1,000) of a Cryptosporidium cell culture infection focus stained with Cy3-labeled
Sporo-Glo antibody (red) and an oocyst stained with FITC-labeled GC Combo antibody (green).
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as a proexcystation treatment (20), but the actual benefits of
trypsin addition have not been assessed. Trypsin production in
the digestive system takes place in the pancreas, and trypsin is
secreted through the pancreatic duct into the duodenum at a
pH of about 8. Trypsin enzymatic activity peaks at pH 7 to 8
(37), and the activity at pH 6 is less than 7% of the peak
activity. A protease active in the stomach at low pH, such as
pepsin (2), appears to be a more feasible physiological enzy-
matic treatment. However, we found that addition of proteases
at low concentrations (0.5% pepsin and 2% trypsin) did not
increase the number focus counts. In fact, acidity was the main
stimulation trigger among all of the conditions tested. This is in
agreement with a previous study (24) which identified body
temperature and stomach acidity (pH 1.5 to 3.5) as the key
stimulating factors. The negative impact of a greater concen-
tration of protease (1% pepsin and 2% trypsin) was not the
result of a pH change, since increasing the protease concen-
trations did not change the sample pH (0.3 pH). Therefore,
our results suggest that protease activity is not a significant
stimulation trigger. Excystation of C. parvum oocysts during
cell culture pretreatment was shown to be marginal (1.3%),
which is desirable for preventing damage to sporozoites during
sample processing and inoculation of monolayers. However,
only C. parvum was tested, and this is an intestinal species.
Gastric species, such as C. muris and C. andersoni, can excyst in
both acidic and neutral conditions. Since C. parvum and C.
hominis are both intestinal species and are the major human-
pathogenic Cryptosporidium species (49), we believe that the
low levels of excystation during cell culture pretreatment have
a negligible effect on the assay.
Addition of bile to the stimulation and infectious media.
Bile had little or no effect when it was added to the stimulation
or infection media. Stimulation media at pH 7.4 mimicked the
physiological conditions of the small intestine, where bile en-
ters the digestive tract. Kato et al. suggested that bile salts
could promote excystation (24). It was hypothesized that ad-
dition of bile to infection media would enhance oocyst excys-
tation, especially after stimulation by acid. To our surprise, our
results showed a clear decrease in the focus counts when bile
was added to the infection media. According to another study,
sodium taurocholate enhanced the invasiveness of freshly ex-
cysted sporozoites by boosting their proteinic secretions and
their gliding motility (14).
Impact of medium selection on infection. The impact of
addition of glucose to the infection media was investigated by
varying the glucose concentration. When 50 mM was added,
the infectivity rate increased. This finding is in agreement with
the findings of Upton et al., who reported that addition of 50
mM glucose increased the amount of parasite (all life stages)
compared to addition of 20 mM (47). However, the counting
method and infection criteria of these workers differed (para-
site life stage counts versus focus counts), and it is possible that
the impact of glucose varies depending on the property as-
sessed (invasion intensity versus infection capacity). These au-
thors also established that addition of galactose, maltose, and
mannose increased the number of parasites recovered. Addi-
tion of 50 mM glucose to the infection media is also part of the
method used in two environmental studies, but the effects of
FIG. 8. Comparison of data reported by the USEPA and measured (this study) oocyst loss for steps of USEPA method 1622/3 and of the
3D-CC-IFA method for two different natural waters and MilliQ water using flow cytometry-sorted C. parvum oocysts. ICRSS, Information
Collection Rule Supplemental Surveys (7). The errors bars indicate standard deviations.
TABLE 2. Impact of the reference total oocyst count on the
calculated percentage of infectious oocysts in experiments
performed at various steps of the 3D-CC-IFA with
spikes of flow cytometry-sorted oocysts
Matrix Steps (n)
% Infectious
oocytes 
avg (SD)a P
Direct Indirect
MilliQ 3D-CC-IFA (10) 19 (4) 12 (1) 0.001
MilliQ IMS  3D-CC-IFA (3) 14 (2) 9 (0) 0.01
Mille-Iles
River
IMS  3D-CC-IFA (2) 13 (3) 5 (1) 0.062
Yamaska
River
IMS  3D-CC-IFA (3) 19 (15) 4 (3) 0.17
a The direct percentages were determined as follows: (number of foci 
100)/(total number of oocyst postinfection steps). And the indirect percentages
were determined as follows: (number of foci  100)/(initial number of oocysts
injected).
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glucose addition on focus counts were not investigated (11, 27).
In this work, elevated concentrations of glucose (300 mM) in
the infection media were found to reduce the number of focus
counts. This concentration of glucose is greater than that com-
monly found in canned fruit juices and juice syrups according
to Health Canada (http://205.193.93.51/cnfonline/), and the ef-
fect may be due to osmotic effects on sporozoites.
Oocyst loss in dual detection procedure. Enumeration of the
total oocysts and enumeration of the infectious oocysts were
combined in a single assay (3D-CC-IFA) in order to minimize
bias from split or paired (but different) samples. Early work
suggested that only about 40% of inoculated oocysts are actu-
ally retained on cell monolayers when samples are analyzed to
determine the number of infectious oocysts using the CC-IFA
method. To fully account for oocyst losses and to determine
the modifications of the method required to minimize these
losses, a mass balance approach was used, which included
counting the oocysts in all sample processing waste streams of
the CC-IFA method. This mass balance analysis revealed that
the 3D-CC-IFA recovered 68%  11% of the seeded flow
cytometry-sorted oocysts, about 28% of which were found in
postinfection waste streams. In order to avoid filtration of
oocysts found in waste streams, several experiments were con-
ducted to facilitate adhesion of oocysts on cell monolayers.
However, as described below, these attempts were not fruitful.
Other studies are required to streamline the filtration steps in
the 3D-CC-IFA method.
Factors affecting oocyst adhesion to the cell monolayer. Ad-
dition of trypsin can increase the translucency of the oocyst
wall and may degrade, modify, or rearrange the oocyst wall
molecules and trigger the adhesion of oocysts (live and dead)
on a cell layer (42). However, in our study addition of trypsin
(1%) did not influence oocyst adhesion (data not shown),
which was likely due to the reduced enzymatic activity of tryp-
sin at low pH. The impact of viability on cell adherence was
assessed. A controlled assay using UV-exposed oocysts was
performed to verify that nonviable oocysts still adhered to
monolayers. It was hypothesized that oocyst viability could be
a significant factor influencing adhesion, which is a critical
issue for application of the 3D-CC-IFA method since the via-
bility of environmental oocysts varies widely (25). The results
indicated that UV inactivation did not influence the number of
oocysts retained on a cell monolayer. The effect of low-volume
inocula was investigated with the objective of enhancing the
contact between the oocysts and the cell monolayer. No sig-
nificant improvements in oocyst adherence were observed.
Other attempts to maximize oocyst adherence, such as addi-
tion of trypsin and longer infection times (72, 96, and 120 h),
did not improve oocyst adherence to cell monolayers or the
numbers of infection foci. Incorporation of the filtration count
technique into the 3D-CC-IFA protocol appeared to be the
best option for obtaining total oocyst counts and attempting to
obtain an oocyst mass balance. The protocol allows recovery of
about 70% of seeded oocysts based on trials with flow cytom-
etry-sorted oocysts.
Selection of antibodies for immunodetection by dual detec-
tion. Although no statistical difference was observed between
the counts obtained with FITC-labeled Crypt-a-Glo alone and
the counts obtained with Cy3-labeled Sporo-Glo and FITC-
labeled GC Combo together, the latter compounds facilitated
and clarified the counts. This combination of compounds is
useful for analysts processing environmental samples, espe-
cially for differentiation of life stages in samples with some
interfering background staining.
Benefits of the 3D-CC-IFA direct count method. The 3D-
CC-IFA method with direct counting allows enumeration of
total and infectious oocysts for the same sample. For an indi-
rect counting method, the numbers of total and infectious
oocysts would have to be estimated by using different samples
(or by splitting a sample), resulting in counts which are subject
to different sources of losses and compounded errors. Method
1623 sample processing probably causes fewer oocyst losses
and errors than the additional sample handling required for
the infectivity assay. Therefore, the indirect counting method
for estimating infectious oocyst fractions is probably not as
accurate as a direct counting method, such as that used for the
3D-CC-IFA method. Estimates of direct and indirect counts
for 3D-CC-IFA and for IMS with 3D-CC-IFA were signifi-
cantly different and highly reproducible when MilliQ water was
used (P 0.01), and the differences were marginally significant
when the Mille-Iles River matrix was used (P  0.07). In
contrast, the high standard deviation for the Yamaska River
data prevented detection of any significant difference, but the
average estimates were always considerably lower. Moreover,
due to the low levels of oocysts in environmental waters, the
use of paired samples introduces additional error into the
estimates, as previously reported for the detection of infectious
and total oocysts. LeChevallier et al. (27) observed that of 22
samples (from a total of 560 paired samples) that tested pos-
itive for infectious oocysts using a cell culture PCR infectivity
assay (CC-PCR), 21 tested negative for oocysts by method
1623. This type of discrepancy can be expected due to the low
levels and distribution of naturally occurring oocysts, as dem-
onstrated by these authors using statistical modeling. Recent
comparative trials of infectivity methods (22) have revealed
that false-positive results are not common when the CC-IFA
method is used. Since the 3D-CC-IFA method uses a direct
enumeration approach to obtain total and infectious oocyst
counts, it has a significant advantage over indirect methods for
analysis of environmental samples with low levels of naturally
occurring oocysts.
Levels of recovery for the 3D-CC-IFA with natural and Mil-
liQ waters. The level of recovery is a critical factor to take into
account, as it may vary considerably from one water matrix to
another. Significant matrix effects have been reported for the
cartridge concentration step and the IMS steps for recovery of
Cryptosporidium from water (7, 32). The proposed method for
environmental waters using Envirochek-HV filter concentra-
tion, IMS purification, and 3D-CC-IFA detection shares the
first two steps with USEPA method 1623. The levels of recov-
ery using method 1623 for analysis of raw surface water sam-
ples vary widely and are often low, ranging from near 0% to
almost 90% (16, 26, 29, 36). Envirochek filtration and IMS
isolation are major contributors to oocyst losses, and they are
both recognized by the USEPA and the United Kingdom’s
Drinking Water Inspectorate (DWI) (12) as procedural steps
that result in oocyst loss. Turbidity is often, but not always,
pointed to as a major contributor to these variations (16, 26,
32). In the current study, the average levels of 3D-CC-IFA
recovery for seeded river water from two different sources were
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25% and 41%, and the turbidities ranged from 10.3 to 13.5
nephelometric turbidity units. The observed contribution of
the IMS isolation step to losses was variable and depended on
the water matrix, as suggested previously (9, 15). The 3D-CC-
IFA method and USEPA method 1623 share the same con-
centration and purification steps, and the level of recovery for
USEPA method 1623 is known to be highly variable, as shown
in Fig. 8. The levels of recovery for water sources are shown as
examples of applications and are expected to be highly variable
depending on the matrix. Compared to typical combined losses
resulting from the concentration and IMS separation steps, the
typical oocyst losses of 30% with the 3D-CC-IFA method ap-
pear to be acceptable, in light of the need to maintain homo-
geneous losses for determination of the infectious fraction. We
believe that once the oocysts are separated, concentrated, and
purified, the matrix effect is not significant at the cell culture
step. Results obtained using CC-IFA infectivity assessment
methods have been shown to correlate with results of animal
assays, providing an interesting alternative to animal trials
(33, 39).
3D-CC-IFA for various Cryptosporidium species. 3D-CC-
IFA results and their applications in risk assessment are clearly
Cryptosporidium species dependent. Given that environmental
samples may contain mixtures of oocysts of various species, the
impact of different speciation may be threefold: (i) a wide
variety of potential infectivity for humans, (ii) different infec-
tivities in cell culture, and (iii) levels of reactivity to detection
antibodies. The extent of this impact cannot be fully evaluated
in control experiments at this time since most environmentally
relevant Cryptosporidium species are not readily available. Var-
ious environmental species would have to be isolated, purified,
and maintained in both cell culture and human trials in order
to fully understand these organisms. C. parvum and C. hominis
are known to develop in cell culture (22) and are certainly the
major species pathogenic to humans (49), and thus they are the
most relevant species for human risk assessment. In terms of
the levels of human infectivity, cell culture methods are known
to be excellent surrogates for animal infectivity assays (33)
when they are used with C. parvum. However, it has to be kept
in mind that even for the same species, different isolates have
significantly different 50% lethal doses in cell culture assays
(33), as well as in human trials (6, 13). The potential differ-
ences in the levels of reactivity to antibodies can be considered
to be low. GC Combo antibody detected many Cryptosporidium
species in a previous study, including C. andersoni, C. parvum,
genotype W12, Cryptosporidium muskrat genotypes I and II, C.
baileyi, Cryptosporidium cervine genotype, and Cryptosporidium
fox genotype (34). An overriding issue is that the Sporo-Glo
antibody, which was developed using C. parvum sporozoite
antigen, detects C. parvum, C. hominis, and C. meleagridis cell
culture clusters of infection but not infection caused by C.
andersoni or C. muris (21; G. D. Di Giovanni, unpublished
data). Therefore, the total oocyst count obtained by 3D-CC-
IFA includes a broad range of oocysts from both human and
animal-associated Cryptosporidium spp. and genotypes, but the
count of infectious oocysts likely only includes the species with
significance for human health.
Conclusion. The combination of total and infectious oocyst
counts for a single sample determined using the 3D-CC-IFA
method provides an improved estimate of the infectious frac-
tion of oocysts. This method can be used for evaluation of
environmental samples, reducing the cost and labor associated
with a paired sample approach, and it should provide better
data for microbial risk analysis. If combined with the speciation
of infection foci (i.e., infectious oocysts) and noninfectious
oocysts present in samples, it would provide key information
for risk assessment. Currently, the Cryptosporidium species
shown to infect HCT-8 cells in vitro include C. parvum, C.
hominis (22), and C. muris (35). Further investigation of other
Cryptosporidium species using the CC-IFA method could re-
veal whether this assay is limited in terms of detection of
infectious oocysts of other species. Enumeration of total oo-
cysts combined with measurement of the infectious fraction
and, in the future, identification of species should provide a
sounder basis on which to assess risk and determine treatment
requirements. This combination of information should enable
the industry to formulate better water treatment strategies
and, ultimately, lead to improved protection of public health.
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